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The study by Solanki and colleagues involved interviewing 166 parents/grandparents at home 
regarding the medications that had been prescribed at discharge to their infants, by the hospital 
staff [1]. As part of the study, the parents were also asked to demonstrate how much medicine they 
would give. With this methodology, Solanki et al. estimated that two out of three of the infants in 
their study would have experienced medication errors at home. This is an alarmingly high proportion 
of medication errors. Fortunately, none of the infants experienced significant harm. The authors 
have suggested that this high rate may be due to lack of parental education and inadequate pre-
discharge counselling. The study was performed in Pondicherry in India. It would be wrong, 
however, to dismiss the relevance of their findings when considering the possibility of medication 
errors among neonates discharged from centres from high income countries, such as the U.K. 
 
How frequent are medication errors? 
Medication errors are often not recognised, and even when detected, often underreported. It is 
difficult to state the prevalence of medication errors in paediatric patients because of the wide 
variation in the definition of medication errors used by different investigators [2]. A literature review 
published in 2007 identified 11 studies looking at medication errors in the neonatal intensive care 
unit (NICU) [2]. The most common type of error in most studies was dosing errors. Dosing errors are 
a potentially major problem in neonates and infants for several reasons. Firstly, ten-fold errors are 
more likely to occur in a neonate or young infant where a small volume of drug is due to be 
administered. Additionally, immaturity of drug metabolism may also predispose to greater toxicity 
rending even small errors to be potentially more damaging than it would in the proportionately 
larger children or adults.  
There have been relatively few studies of medication errors in infants or children at home. An 
American study of children with malignancies identified 72 medication errors occurring at home in a 
group of 92 children [3]. They identified a 70% risk of errors occurring in their patients, which is 
remarkably similar to the findings by Solanki. 
 
Clinical significance 
Most prospective studies of medication errors or adverse drug reactions do not detect significant 
toxicity due to the small number of patients involved in the study. In order to detect significant 
toxicity, one needs to use a different approach. A novel approach was to look at newspaper reports 
involving medicines. Over an eight year period (1993-2000) in the UK, there were at least 29 deaths 
in paediatric patients due to medication errors [4]. Nine of these 29 deaths involved neonates and 
the most frequent type of medication error involved an incorrect dose.  
The American study of children with malignancies identified four medication errors that resulted in 
significant patient injury in their group of 92 patients [3]. Additionally, there were two life 
threatening errors which did not result in injury. These findings therefore suggest that significant 
medication errors in infants at home may be more common than generally assumed. The clinical 
significance of medication errors in paediatric patients at home remains unknown and can only be 
answered by large pharmacovigilance studies involving families and reaching out into homes. Infants 
are at greater risk of drug toxicity for a variety of reasons. Drug elimination pathways (both hepatic 
and renal) are not fully developed in neonates and young infants, particularly those born 
prematurely [5]. Over the years such physiological immaturities have come into focus due to now 
well known drug toxicities such as, the grey baby syndrome (chloramphenicol), kernicterus 
(sulphonamides), hepatotoxicity (sodium valproate), calcium precipitation (ceftriaxone and calcium 
containing solutions) and Reye’s syndrome (salicylate) [5]. 
Some groups of medications are more likely to be associated with clinically significant toxicity 
following a medication error [6]. Cytotoxics, antiepileptics, opiates and insulin all may be associated 
with significant toxicity following dosing errors. One therefore needs to take greater care with such 
medications. Most infants in the U.K. are discharged home on medications such as multivitamins and 
iron supplements, similar to the participants of Solanki et al. and these medications are believed to 
be relatively innocuous even if minor medications errors occur. However, as highlighted by Solanki 
et al., large volume errors are common and it is possible that infants may be subjected to 
unnecessary risks if parents are not appropriately empowered to deliver medications at home. In 
addition, it is worth considering that with increasing trends or early discharges from both postnatal 
wards and neonatal units, more and more infants are likely to be discharged on short and long term 
medications that will need to be delivered at home by the parents. In this scenario the findings of 
Solanki et al. is a worthwhile reminder of the need to extend pharmacovigilance to include delivery 
of drugs at home. 
 
Minimising medication errors at home 
It is not possible to eliminate every single medication error. It is however possible to reduce the 
likelihood of the occurrence of a significant medication error. Firstly, the importance of giving 
appropriate information to parents when their infant is discharged from hospital should be 
recognised. Discharging a patient is usually left to the most junior doctor whose education, 
therefore, must include the importance of educating parents. Written information needs to be 
comprehensible to the patient. It is of concern that in the study in Pondicherry that prescriptions 
were written in English, a language that most of the parents were unable to read. This too might be 
relevant in the current multicultural milieu in the U.K. Greater care needs to be given when 
discharging infants on potentially toxic medications such as anti-epileptic drugs. Additionally, 
additional safeguards such as ensuring that community health professionals prescribe and dispense 
formulations of the same strength as that prescribed on discharged from hospitals. The 
responsibility for minimising medication errors to infants at home should rest primarily on health 
professionals, not parents and our jobs should include empowering parents to care for their infant. 
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